Natixis lifted its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 36.5% in the second quarter, according to its most recent filing with the SEC. The fund owned 22,426 shares of the company’s stock after acquiring an additional 6,001 shares during the period. Natixis’ holdings in Neurocrine Biosciences were worth $2,115,000 […]